nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—PLA2G4A—Carbachol—glaucoma	0.376	0.833	CbGbCtD
Fluticasone Propionate—NR3C1—glaucoma	0.325	1	CbGaD
Fluticasone Propionate—CYP3A5—Clonidine—glaucoma	0.0172	0.038	CbGbCtD
Fluticasone Propionate—CYP3A4—Pilocarpine—glaucoma	0.0137	0.0304	CbGbCtD
Fluticasone Propionate—CYP3A4—Brinzolamide—glaucoma	0.0107	0.0238	CbGbCtD
Fluticasone Propionate—CYP3A4—Dorzolamide—glaucoma	0.0104	0.023	CbGbCtD
Fluticasone Propionate—CYP3A4—Methazolamide—glaucoma	0.00925	0.0205	CbGbCtD
Fluticasone Propionate—CYP3A4—Acetazolamide—glaucoma	0.0074	0.0164	CbGbCtD
Fluticasone Propionate—CYP3A4—Clonidine—glaucoma	0.00669	0.0148	CbGbCtD
Fluticasone Propionate—NR3C2—ACE Inhibitor Pathway—MAS1—glaucoma	0.00348	0.144	CbGpPWpGaD
Fluticasone Propionate—NR3C2—ACE Inhibitor Pathway—ACE2—glaucoma	0.00264	0.109	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.00133	0.055	CbGpPWpGaD
Fluticasone Propionate—PGR—Validated nuclear estrogen receptor alpha network—POU4F2—glaucoma	0.00128	0.053	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.000906	0.0375	CbGpPWpGaD
Fluticasone Propionate—Fluocinonide—SMO—glaucoma	0.000854	0.159	CrCbGaD
Fluticasone Propionate—PLA2G4A—Pindolol—Levobunolol—glaucoma	0.000771	0.276	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Pindolol—Carteolol—glaucoma	0.000771	0.276	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Pindolol—Metipranolol—glaucoma	0.000736	0.263	CbGdCrCtD
Fluticasone Propionate—PGR—Validated nuclear estrogen receptor alpha network—POU4F1—glaucoma	0.000701	0.029	CbGpPWpGaD
Fluticasone Propionate—NR3C2—ACE Inhibitor Pathway—NOS3—glaucoma	0.000581	0.0241	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Pindolol—Betaxolol—glaucoma	0.000514	0.184	CbGdCrCtD
Fluticasone Propionate—PGR—Ovarian Infertility Genes—CCND2—glaucoma	0.000407	0.0169	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—p38 MAPK Signaling Pathway—TGFB2—glaucoma	0.000396	0.0164	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00037	0.0153	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.000362	0.015	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Signaling events mediated by HDAC Class II—HDAC9—glaucoma	0.000342	0.0142	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.000308	0.0128	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000301	0.0125	CbGpPWpGaD
Fluticasone Propionate—PGR—Nuclear Receptors—NR3C1—glaucoma	0.000279	0.0116	CbGpPWpGaD
Fluticasone Propionate—Difluprednate—NR3C1—glaucoma	0.000275	0.0512	CrCbGaD
Fluticasone Propionate—Clocortolone—NR3C1—glaucoma	0.000267	0.0497	CrCbGaD
Fluticasone Propionate—Prednicarbate—NR3C1—glaucoma	0.000267	0.0497	CrCbGaD
Fluticasone Propionate—Diflorasone—NR3C1—glaucoma	0.000252	0.047	CrCbGaD
Fluticasone Propionate—CYP3A5—Tamoxifen metabolism—CYP1B1—glaucoma	0.000249	0.0103	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000247	0.0103	CbGpPWpGaD
Fluticasone Propionate—Desoximetasone—NR3C1—glaucoma	0.000246	0.0459	CrCbGaD
Fluticasone Propionate—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000228	0.00947	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000223	0.00925	CbGpPWpGaD
Fluticasone Propionate—PGR—Validated nuclear estrogen receptor alpha network—SOD1—glaucoma	0.000222	0.00918	CbGpPWpGaD
Fluticasone Propionate—PGR—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.000221	0.00914	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—NCK2—glaucoma	0.000219	0.00908	CbGpPWpGaD
Fluticasone Propionate—Flumethasone Pivalate—NR3C1—glaucoma	0.000212	0.0395	CrCbGaD
Fluticasone Propionate—Halobetasol Propionate—NR3C1—glaucoma	0.000208	0.0388	CrCbGaD
Fluticasone Propionate—Amcinonide—NR3C1—glaucoma	0.000194	0.0361	CrCbGaD
Fluticasone Propionate—Fluticasone furoate—NR3C1—glaucoma	0.00019	0.0354	CrCbGaD
Fluticasone Propionate—PGR—Ovarian Infertility Genes—CDKN1B—glaucoma	0.000185	0.00765	CbGpPWpGaD
Fluticasone Propionate—Mometasone—NR3C1—glaucoma	0.000184	0.0343	CrCbGaD
Fluticasone Propionate—Rimexolone—NR3C1—glaucoma	0.000182	0.0339	CrCbGaD
Fluticasone Propionate—PGR—Cellular roles of Anthrax toxin—TNF—glaucoma	0.000178	0.00736	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—SOD1—glaucoma	0.000177	0.00732	CbGpPWpGaD
Fluticasone Propionate—PGR—Validated nuclear estrogen receptor alpha network—C3—glaucoma	0.000176	0.00728	CbGpPWpGaD
Fluticasone Propionate—Beclomethasone—NR3C1—glaucoma	0.000172	0.032	CrCbGaD
Fluticasone Propionate—Fluocinonide—NR3C1—glaucoma	0.000172	0.032	CrCbGaD
Fluticasone Propionate—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.000168	0.00695	CbGpPWpGaD
Fluticasone Propionate—Fluocinolone Acetonide—NR3C1—glaucoma	0.000167	0.0311	CrCbGaD
Fluticasone Propionate—Alclometasone—NR3C1—glaucoma	0.000167	0.0311	CrCbGaD
Fluticasone Propionate—PLA2G4A—Endothelins—EDN1—glaucoma	0.000166	0.00689	CbGpPWpGaD
Fluticasone Propionate—Flunisolide—NR3C1—glaucoma	0.000163	0.0303	CrCbGaD
Fluticasone Propionate—Clobetasol propionate—NR3C1—glaucoma	0.000163	0.0303	CrCbGaD
Fluticasone Propionate—Paramethasone—NR3C1—glaucoma	0.000161	0.0299	CrCbGaD
Fluticasone Propionate—Fluorometholone—NR3C1—glaucoma	0.000157	0.0292	CrCbGaD
Fluticasone Propionate—Methylprednisolone—NR3C1—glaucoma	0.000152	0.0282	CrCbGaD
Fluticasone Propionate—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000149	0.00617	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—glaucoma	0.000148	0.00615	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000147	0.00609	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Endothelins—MMP1—glaucoma	0.00014	0.00579	CbGpPWpGaD
Fluticasone Propionate—Cardiac disorder—Clonidine—glaucoma	0.000134	0.000699	CcSEcCtD
Fluticasone Propionate—Arthralgia—Pilocarpine—glaucoma	0.000134	0.000699	CcSEcCtD
Fluticasone Propionate—Chest pain—Pilocarpine—glaucoma	0.000134	0.000699	CcSEcCtD
Fluticasone Propionate—Anxiety—Pilocarpine—glaucoma	0.000133	0.000696	CcSEcCtD
Fluticasone Propionate—Nausea—Levobunolol—glaucoma	0.000132	0.000693	CcSEcCtD
Fluticasone Propionate—Infection—Brinzolamide—glaucoma	0.000132	0.000693	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Travoprost—glaucoma	0.000132	0.000692	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Timolol—glaucoma	0.000132	0.000692	CcSEcCtD
Fluticasone Propionate—Discomfort—Pilocarpine—glaucoma	0.000132	0.000691	CcSEcCtD
Fluticasone Propionate—Tachycardia—Travoprost—glaucoma	0.000132	0.000689	CcSEcCtD
Fluticasone Propionate—Epistaxis—Betaxolol—glaucoma	0.000132	0.000689	CcSEcCtD
Fluticasone Propionate—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000131	0.00544	CbGpPWpGaD
Fluticasone Propionate—Skin disorder—Travoprost—glaucoma	0.000131	0.000686	CcSEcCtD
Fluticasone Propionate—Sinusitis—Betaxolol—glaucoma	0.000131	0.000685	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Apraclonidine—glaucoma	0.000131	0.000684	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Brinzolamide—glaucoma	0.000131	0.000684	CcSEcCtD
Fluticasone Propionate—Rash—Latanoprost—glaucoma	0.00013	0.000682	CcSEcCtD
Fluticasone Propionate—Dermatitis—Latanoprost—glaucoma	0.00013	0.000681	CcSEcCtD
Fluticasone Propionate—Tachycardia—Brinzolamide—glaucoma	0.00013	0.00068	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Clonidine—glaucoma	0.00013	0.000679	CcSEcCtD
Fluticasone Propionate—Headache—Latanoprost—glaucoma	0.00013	0.000678	CcSEcCtD
Fluticasone Propionate—Skin disorder—Brinzolamide—glaucoma	0.000129	0.000677	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000129	0.000676	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Clonidine—glaucoma	0.000129	0.000673	CcSEcCtD
Fluticasone Propionate—Oedema—Pilocarpine—glaucoma	0.000128	0.00067	CcSEcCtD
Fluticasone Propionate—Asthma—Timolol—glaucoma	0.000128	0.000669	CcSEcCtD
Fluticasone Propionate—Triamcinolone—NR3C1—glaucoma	0.000128	0.0238	CrCbGaD
Fluticasone Propionate—Infection—Pilocarpine—glaucoma	0.000127	0.000666	CcSEcCtD
Fluticasone Propionate—Nausea—Methazolamide—glaucoma	0.000127	0.000664	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Brimonidine—glaucoma	0.000127	0.000662	CcSEcCtD
Fluticasone Propionate—Mental disorder—Clonidine—glaucoma	0.000126	0.00066	CcSEcCtD
Fluticasone Propionate—Bronchospasm—Timolol—glaucoma	0.000126	0.000658	CcSEcCtD
Fluticasone Propionate—Erythema—Clonidine—glaucoma	0.000125	0.000656	CcSEcCtD
Fluticasone Propionate—Tachycardia—Pilocarpine—glaucoma	0.000125	0.000654	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Betaxolol—glaucoma	0.000125	0.000652	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Betaxolol—glaucoma	0.000124	0.000651	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000123	0.000646	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Travoprost—glaucoma	0.000123	0.000643	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Acetazolamide—glaucoma	0.000122	0.000637	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Apraclonidine—glaucoma	0.000122	0.000637	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000121	0.000635	CcSEcCtD
Fluticasone Propionate—Pain—Brimonidine—glaucoma	0.000121	0.000635	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Dorzolamide—glaucoma	0.000121	0.000632	CcSEcCtD
Fluticasone Propionate—CYP3A7—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000121	0.00501	CbGpPWpGaD
Fluticasone Propionate—Muscle spasms—Clonidine—glaucoma	0.00012	0.00063	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Travoprost—glaucoma	0.00012	0.000629	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Timolol—glaucoma	0.000119	0.000622	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Brinzolamide—glaucoma	0.000119	0.000621	CcSEcCtD
Fluticasone Propionate—Vision blurred—Clonidine—glaucoma	0.000118	0.000618	CcSEcCtD
Fluticasone Propionate—Urticaria—Acetazolamide—glaucoma	0.000117	0.000615	CcSEcCtD
Fluticasone Propionate—Tremor—Clonidine—glaucoma	0.000117	0.000614	CcSEcCtD
Fluticasone Propionate—Eye disorder—Betaxolol—glaucoma	0.000117	0.000613	CcSEcCtD
Fluticasone Propionate—Pruritus—Apraclonidine—glaucoma	0.000117	0.000612	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Acetazolamide—glaucoma	0.000117	0.000612	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000117	0.00061	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Betaxolol—glaucoma	0.000116	0.000609	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Clonidine—glaucoma	0.000116	0.000608	CcSEcCtD
Fluticasone Propionate—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000116	0.00481	CbGpPWpGaD
Fluticasone Propionate—Pain—Dorzolamide—glaucoma	0.000116	0.000606	CcSEcCtD
Fluticasone Propionate—Pain—Travoprost—glaucoma	0.000115	0.000604	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Timolol—glaucoma	0.000115	0.000604	CcSEcCtD
Fluticasone Propionate—Agitation—Clonidine—glaucoma	0.000115	0.000602	CcSEcCtD
Fluticasone Propionate—Angioedema—Clonidine—glaucoma	0.000115	0.000599	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Pilocarpine—glaucoma	0.000114	0.000597	CcSEcCtD
Fluticasone Propionate—Pain—Brinzolamide—glaucoma	0.000114	0.000596	CcSEcCtD
Fluticasone Propionate—Pruritus—Bimatoprost—glaucoma	0.000113	0.000593	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Betaxolol—glaucoma	0.000113	0.000592	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Apraclonidine—glaucoma	0.000113	0.000592	CcSEcCtD
Fluticasone Propionate—Malaise—Clonidine—glaucoma	0.000113	0.000591	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Betaxolol—glaucoma	0.000113	0.000591	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Betaxolol—glaucoma	0.000112	0.000586	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Dorzolamide—glaucoma	0.000112	0.000584	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Arachidonic acid metabolism—PTGS2—glaucoma	0.000112	0.00462	CbGpPWpGaD
Fluticasone Propionate—Feeling abnormal—Travoprost—glaucoma	0.000111	0.000582	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Timolol—glaucoma	0.000111	0.00058	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Dorzolamide—glaucoma	0.000111	0.00058	CcSEcCtD
Fluticasone Propionate—Palpitations—Clonidine—glaucoma	0.000111	0.000579	CcSEcCtD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.00011	0.00458	CbGpPWpGaD
Fluticasone Propionate—Gastrointestinal pain—Travoprost—glaucoma	0.00011	0.000577	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Brinzolamide—glaucoma	0.00011	0.000574	CcSEcCtD
Fluticasone Propionate—Mental disorder—Betaxolol—glaucoma	0.00011	0.000574	CcSEcCtD
Fluticasone Propionate—Pain—Pilocarpine—glaucoma	0.00011	0.000573	CcSEcCtD
Fluticasone Propionate—Cough—Clonidine—glaucoma	0.000109	0.000572	CcSEcCtD
Fluticasone Propionate—Dizziness—Apraclonidine—glaucoma	0.000109	0.000572	CcSEcCtD
Fluticasone Propionate—Erythema—Betaxolol—glaucoma	0.000109	0.000571	CcSEcCtD
Fluticasone Propionate—Malnutrition—Betaxolol—glaucoma	0.000109	0.000571	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—EDN1—glaucoma	0.000108	0.00448	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000108	0.00446	CbGpPWpGaD
Fluticasone Propionate—Urticaria—Dorzolamide—glaucoma	0.000108	0.000563	CcSEcCtD
Fluticasone Propionate—Epistaxis—Timolol—glaucoma	0.000108	0.000563	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Dorzolamide—glaucoma	0.000107	0.000561	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Dorzolamide—glaucoma	0.000107	0.000561	CcSEcCtD
Fluticasone Propionate—Sinusitis—Timolol—glaucoma	0.000107	0.00056	CcSEcCtD
Fluticasone Propionate—Arthralgia—Clonidine—glaucoma	0.000107	0.000558	CcSEcCtD
Fluticasone Propionate—Chest pain—Clonidine—glaucoma	0.000107	0.000558	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Travoprost—glaucoma	0.000107	0.000558	CcSEcCtD
Fluticasone Propionate—Anxiety—Clonidine—glaucoma	0.000106	0.000556	CcSEcCtD
Fluticasone Propionate—CYP3A5—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000106	0.0044	CbGpPWpGaD
Fluticasone Propionate—Dizziness—Bimatoprost—glaucoma	0.000106	0.000554	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000106	0.000554	CcSEcCtD
Fluticasone Propionate—Urticaria—Brinzolamide—glaucoma	0.000106	0.000554	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Pilocarpine—glaucoma	0.000106	0.000552	CcSEcCtD
Fluticasone Propionate—Discomfort—Clonidine—glaucoma	0.000105	0.000551	CcSEcCtD
Fluticasone Propionate—Vomiting—Apraclonidine—glaucoma	0.000105	0.00055	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Betaxolol—glaucoma	0.000105	0.000549	CcSEcCtD
Fluticasone Propionate—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000105	0.00435	CbGpPWpGaD
Fluticasone Propionate—Gastrointestinal pain—Pilocarpine—glaucoma	0.000105	0.000548	CcSEcCtD
Fluticasone Propionate—Betamethasone—NR3C1—glaucoma	0.000105	0.0195	CrCbGaD
Fluticasone Propionate—Hypersensitivity—Brimonidine—glaucoma	0.000105	0.000547	CcSEcCtD
Fluticasone Propionate—Dry mouth—Clonidine—glaucoma	0.000104	0.000546	CcSEcCtD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—MMP2—glaucoma	0.000104	0.00432	CbGpPWpGaD
Fluticasone Propionate—Dermatitis—Apraclonidine—glaucoma	0.000104	0.000545	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000104	0.0043	CbGpPWpGaD
Fluticasone Propionate—Headache—Apraclonidine—glaucoma	0.000104	0.000542	CcSEcCtD
Fluticasone Propionate—Vision blurred—Betaxolol—glaucoma	0.000103	0.000538	CcSEcCtD
Fluticasone Propionate—NR3C1—Transcription factor regulation in adipogenesis—TNF—glaucoma	0.000103	0.00426	CbGpPWpGaD
Fluticasone Propionate—Dexamethasone—CYP1B1—glaucoma	0.000102	0.0191	CrCbGaD
Fluticasone Propionate—Oedema—Clonidine—glaucoma	0.000102	0.000535	CcSEcCtD
Fluticasone Propionate—Tremor—Betaxolol—glaucoma	0.000102	0.000535	CcSEcCtD
Fluticasone Propionate—Infection—Clonidine—glaucoma	0.000102	0.000532	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Pilocarpine—glaucoma	0.000101	0.00053	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Pilocarpine—glaucoma	0.000101	0.00053	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Betaxolol—glaucoma	0.000101	0.00053	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Acetazolamide—glaucoma	0.000101	0.000529	CcSEcCtD
Fluticasone Propionate—Rash—Bimatoprost—glaucoma	0.000101	0.000529	CcSEcCtD
Fluticasone Propionate—Dermatitis—Bimatoprost—glaucoma	0.000101	0.000528	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Timolol—glaucoma	0.000101	0.000526	CcSEcCtD
Fluticasone Propionate—Pruritus—Brimonidine—glaucoma	0.0001	0.000525	CcSEcCtD
Fluticasone Propionate—Headache—Bimatoprost—glaucoma	0.0001	0.000525	CcSEcCtD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	0.0001	0.00416	CbGpPWpGaD
Fluticasone Propionate—Nervous system disorder—Clonidine—glaucoma	0.0001	0.000525	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Dorzolamide—glaucoma	9.99e-05	0.000522	CcSEcCtD
Fluticasone Propionate—Tachycardia—Clonidine—glaucoma	9.98e-05	0.000522	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Travoprost—glaucoma	9.94e-05	0.00052	CcSEcCtD
Fluticasone Propionate—Skin disorder—Clonidine—glaucoma	9.94e-05	0.00052	CcSEcCtD
Fluticasone Propionate—Malaise—Betaxolol—glaucoma	9.84e-05	0.000515	CcSEcCtD
Fluticasone Propionate—Nausea—Apraclonidine—glaucoma	9.82e-05	0.000514	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Brinzolamide—glaucoma	9.82e-05	0.000514	CcSEcCtD
Fluticasone Propionate—Dizziness—Acetazolamide—glaucoma	9.78e-05	0.000512	CcSEcCtD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—NOS3—glaucoma	9.76e-05	0.00405	CbGpPWpGaD
Fluticasone Propionate—Palpitations—Betaxolol—glaucoma	9.64e-05	0.000504	CcSEcCtD
Fluticasone Propionate—Pruritus—Dorzolamide—glaucoma	9.59e-05	0.000502	CcSEcCtD
Fluticasone Propionate—Eye disorder—Timolol—glaucoma	9.57e-05	0.000501	CcSEcCtD
Fluticasone Propionate—Pruritus—Travoprost—glaucoma	9.55e-05	0.000499	CcSEcCtD
Fluticasone Propionate—Cough—Betaxolol—glaucoma	9.52e-05	0.000498	CcSEcCtD
Fluticasone Propionate—Nausea—Bimatoprost—glaucoma	9.52e-05	0.000498	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Timolol—glaucoma	9.5e-05	0.000497	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Pilocarpine—glaucoma	9.44e-05	0.000494	CcSEcCtD
Fluticasone Propionate—Pruritus—Brinzolamide—glaucoma	9.43e-05	0.000493	CcSEcCtD
Fluticasone Propionate—Vomiting—Acetazolamide—glaucoma	9.4e-05	0.000492	CcSEcCtD
Fluticasone Propionate—Dizziness—Brimonidine—glaucoma	9.39e-05	0.000491	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Clonidine—glaucoma	9.32e-05	0.000487	CcSEcCtD
Fluticasone Propionate—Chest pain—Betaxolol—glaucoma	9.29e-05	0.000486	CcSEcCtD
Fluticasone Propionate—Arthralgia—Betaxolol—glaucoma	9.29e-05	0.000486	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Dorzolamide—glaucoma	9.27e-05	0.000485	CcSEcCtD
Fluticasone Propionate—Headache—Acetazolamide—glaucoma	9.26e-05	0.000485	CcSEcCtD
Fluticasone Propionate—Anxiety—Betaxolol—glaucoma	9.26e-05	0.000484	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Timolol—glaucoma	9.25e-05	0.000484	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Travoprost—glaucoma	9.23e-05	0.000483	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Timolol—glaucoma	9.23e-05	0.000483	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	9.23e-05	0.000483	CcSEcCtD
Fluticasone Propionate—Discomfort—Betaxolol—glaucoma	9.18e-05	0.00048	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Timolol—glaucoma	9.15e-05	0.000478	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Clonidine—glaucoma	9.12e-05	0.000477	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Brinzolamide—glaucoma	9.12e-05	0.000477	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—MMP1—glaucoma	9.09e-05	0.00377	CbGpPWpGaD
Fluticasone Propionate—Dry mouth—Betaxolol—glaucoma	9.08e-05	0.000475	CcSEcCtD
Fluticasone Propionate—Pruritus—Pilocarpine—glaucoma	9.06e-05	0.000474	CcSEcCtD
Fluticasone Propionate—Mental disorder—Timolol—glaucoma	8.97e-05	0.000469	CcSEcCtD
Fluticasone Propionate—Dizziness—Dorzolamide—glaucoma	8.96e-05	0.000469	CcSEcCtD
Fluticasone Propionate—Rash—Brimonidine—glaucoma	8.95e-05	0.000468	CcSEcCtD
Fluticasone Propionate—Dermatitis—Brimonidine—glaucoma	8.94e-05	0.000468	CcSEcCtD
Fluticasone Propionate—Dizziness—Travoprost—glaucoma	8.92e-05	0.000467	CcSEcCtD
Fluticasone Propionate—Erythema—Timolol—glaucoma	8.91e-05	0.000466	CcSEcCtD
Fluticasone Propionate—Malnutrition—Timolol—glaucoma	8.91e-05	0.000466	CcSEcCtD
Fluticasone Propionate—Oedema—Betaxolol—glaucoma	8.9e-05	0.000466	CcSEcCtD
Fluticasone Propionate—Headache—Brimonidine—glaucoma	8.89e-05	0.000465	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—TGFB2—glaucoma	8.86e-05	0.00367	CbGpPWpGaD
Fluticasone Propionate—Infection—Betaxolol—glaucoma	8.85e-05	0.000463	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	8.83e-05	0.00366	CbGpPWpGaD
Fluticasone Propionate—Dizziness—Brinzolamide—glaucoma	8.81e-05	0.000461	CcSEcCtD
Fluticasone Propionate—Nausea—Acetazolamide—glaucoma	8.78e-05	0.000459	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Pilocarpine—glaucoma	8.76e-05	0.000458	CcSEcCtD
Fluticasone Propionate—Pain—Clonidine—glaucoma	8.75e-05	0.000458	CcSEcCtD
Fluticasone Propionate—CYP3A5—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	8.73e-05	0.00362	CbGpPWpGaD
Fluticasone Propionate—Nervous system disorder—Betaxolol—glaucoma	8.73e-05	0.000457	CcSEcCtD
Fluticasone Propionate—Tachycardia—Betaxolol—glaucoma	8.69e-05	0.000455	CcSEcCtD
Fluticasone Propionate—Skin disorder—Betaxolol—glaucoma	8.65e-05	0.000452	CcSEcCtD
Fluticasone Propionate—Vomiting—Dorzolamide—glaucoma	8.62e-05	0.000451	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—CTSA—glaucoma	8.6e-05	0.00356	CbGpPWpGaD
Fluticasone Propionate—Rash—Dorzolamide—glaucoma	8.55e-05	0.000447	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Platelet homeostasis—NOS3—glaucoma	8.54e-05	0.00354	CbGpPWpGaD
Fluticasone Propionate—Dermatitis—Dorzolamide—glaucoma	8.54e-05	0.000447	CcSEcCtD
Fluticasone Propionate—Rash—Travoprost—glaucoma	8.51e-05	0.000445	CcSEcCtD
Fluticasone Propionate—Dermatitis—Travoprost—glaucoma	8.5e-05	0.000445	CcSEcCtD
Fluticasone Propionate—Headache—Dorzolamide—glaucoma	8.49e-05	0.000444	CcSEcCtD
Fluticasone Propionate—Vomiting—Brinzolamide—glaucoma	8.47e-05	0.000443	CcSEcCtD
Fluticasone Propionate—Dizziness—Pilocarpine—glaucoma	8.47e-05	0.000443	CcSEcCtD
Fluticasone Propionate—Headache—Travoprost—glaucoma	8.46e-05	0.000442	CcSEcCtD
Fluticasone Propionate—Nausea—Brimonidine—glaucoma	8.43e-05	0.000441	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Clonidine—glaucoma	8.43e-05	0.000441	CcSEcCtD
Fluticasone Propionate—Rash—Brinzolamide—glaucoma	8.4e-05	0.00044	CcSEcCtD
Fluticasone Propionate—Vision blurred—Timolol—glaucoma	8.4e-05	0.000439	CcSEcCtD
Fluticasone Propionate—Dermatitis—Brinzolamide—glaucoma	8.39e-05	0.000439	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Clonidine—glaucoma	8.36e-05	0.000438	CcSEcCtD
Fluticasone Propionate—Headache—Brinzolamide—glaucoma	8.35e-05	0.000437	CcSEcCtD
Fluticasone Propionate—Angioedema—Timolol—glaucoma	8.14e-05	0.000426	CcSEcCtD
Fluticasone Propionate—Vomiting—Pilocarpine—glaucoma	8.14e-05	0.000426	CcSEcCtD
Fluticasone Propionate—Urticaria—Clonidine—glaucoma	8.13e-05	0.000425	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Betaxolol—glaucoma	8.11e-05	0.000424	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Metabolism—NARFL—glaucoma	8.1e-05	0.00336	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CA5A—glaucoma	8.1e-05	0.00336	CbGpPWpGaD
Fluticasone Propionate—Abdominal pain—Clonidine—glaucoma	8.09e-05	0.000423	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Clonidine—glaucoma	8.09e-05	0.000423	CcSEcCtD
Fluticasone Propionate—Rash—Pilocarpine—glaucoma	8.08e-05	0.000422	CcSEcCtD
Fluticasone Propionate—Dermatitis—Pilocarpine—glaucoma	8.07e-05	0.000422	CcSEcCtD
Fluticasone Propionate—CYP3A7—Biological oxidations—GSTT1—glaucoma	8.05e-05	0.00334	CbGpPWpGaD
Fluticasone Propionate—Nausea—Dorzolamide—glaucoma	8.05e-05	0.000421	CcSEcCtD
Fluticasone Propionate—Headache—Pilocarpine—glaucoma	8.02e-05	0.00042	CcSEcCtD
Fluticasone Propionate—Nausea—Travoprost—glaucoma	8.02e-05	0.000419	CcSEcCtD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—MMP1—glaucoma	8.01e-05	0.00332	CbGpPWpGaD
Fluticasone Propionate—Dyspnoea—Betaxolol—glaucoma	7.94e-05	0.000415	CcSEcCtD
Fluticasone Propionate—Nausea—Brinzolamide—glaucoma	7.92e-05	0.000414	CcSEcCtD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—NTRK2—glaucoma	7.9e-05	0.00327	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	7.89e-05	0.00327	CbGpPWpGaD
Fluticasone Propionate—Palpitations—Timolol—glaucoma	7.88e-05	0.000412	CcSEcCtD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—MMP9—glaucoma	7.83e-05	0.00325	CbGpPWpGaD
Fluticasone Propionate—Cough—Timolol—glaucoma	7.78e-05	0.000407	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	7.75e-05	0.00321	CbGpPWpGaD
Fluticasone Propionate—Hypertension—Timolol—glaucoma	7.7e-05	0.000403	CcSEcCtD
Fluticasone Propionate—PGR—Signaling by ERBB4—BAD—glaucoma	7.63e-05	0.00316	CbGpPWpGaD
Fluticasone Propionate—Pain—Betaxolol—glaucoma	7.61e-05	0.000398	CcSEcCtD
Fluticasone Propionate—Nausea—Pilocarpine—glaucoma	7.61e-05	0.000398	CcSEcCtD
Fluticasone Propionate—Arthralgia—Timolol—glaucoma	7.59e-05	0.000397	CcSEcCtD
Fluticasone Propionate—Chest pain—Timolol—glaucoma	7.59e-05	0.000397	CcSEcCtD
Fluticasone Propionate—Anxiety—Timolol—glaucoma	7.56e-05	0.000396	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	7.54e-05	0.000394	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Clonidine—glaucoma	7.54e-05	0.000394	CcSEcCtD
Fluticasone Propionate—Discomfort—Timolol—glaucoma	7.5e-05	0.000392	CcSEcCtD
Fluticasone Propionate—Dry mouth—Timolol—glaucoma	7.42e-05	0.000388	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Betaxolol—glaucoma	7.34e-05	0.000384	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Timolol—glaucoma	7.27e-05	0.000381	CcSEcCtD
Fluticasone Propionate—Oedema—Timolol—glaucoma	7.27e-05	0.000381	CcSEcCtD
Fluticasone Propionate—Triamcinolone—PTGS2—glaucoma	7.25e-05	0.0135	CrCbGaD
Fluticasone Propionate—Pruritus—Clonidine—glaucoma	7.24e-05	0.000379	CcSEcCtD
Fluticasone Propionate—Infection—Timolol—glaucoma	7.23e-05	0.000378	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	7.14e-05	0.00296	CbGpPWpGaD
Fluticasone Propionate—Nervous system disorder—Timolol—glaucoma	7.13e-05	0.000373	CcSEcCtD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—CDKN2B—glaucoma	7.13e-05	0.00295	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	7.09e-05	0.00294	CbGpPWpGaD
Fluticasone Propionate—Urticaria—Betaxolol—glaucoma	7.07e-05	0.00037	CcSEcCtD
Fluticasone Propionate—Skin disorder—Timolol—glaucoma	7.07e-05	0.00037	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Betaxolol—glaucoma	7.04e-05	0.000368	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Clonidine—glaucoma	7e-05	0.000366	CcSEcCtD
Fluticasone Propionate—Dizziness—Clonidine—glaucoma	6.76e-05	0.000354	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—SOD1—glaucoma	6.72e-05	0.00278	CbGpPWpGaD
Fluticasone Propionate—Musculoskeletal discomfort—Timolol—glaucoma	6.63e-05	0.000347	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Betaxolol—glaucoma	6.56e-05	0.000343	CcSEcCtD
Fluticasone Propionate—Vomiting—Clonidine—glaucoma	6.5e-05	0.00034	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Timolol—glaucoma	6.49e-05	0.000339	CcSEcCtD
Fluticasone Propionate—Rash—Clonidine—glaucoma	6.45e-05	0.000337	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—CDKN2A—glaucoma	6.45e-05	0.00267	CbGpPWpGaD
Fluticasone Propionate—Dermatitis—Clonidine—glaucoma	6.44e-05	0.000337	CcSEcCtD
Fluticasone Propionate—CYP3A7—Biological oxidations—CYP1B1—glaucoma	6.42e-05	0.00266	CbGpPWpGaD
Fluticasone Propionate—Headache—Clonidine—glaucoma	6.41e-05	0.000335	CcSEcCtD
Fluticasone Propionate—CYP3A7—Metapathway biotransformation—CYP1B1—glaucoma	6.33e-05	0.00262	CbGpPWpGaD
Fluticasone Propionate—Pruritus—Betaxolol—glaucoma	6.3e-05	0.00033	CcSEcCtD
Fluticasone Propionate—PGR—Signaling Pathways—LRP12—glaucoma	6.28e-05	0.0026	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—NR3C1—glaucoma	6.25e-05	0.00259	CbGpPWpGaD
Fluticasone Propionate—Pain—Timolol—glaucoma	6.22e-05	0.000325	CcSEcCtD
Fluticasone Propionate—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	6.19e-05	0.00257	CbGpPWpGaD
Fluticasone Propionate—Diarrhoea—Betaxolol—glaucoma	6.09e-05	0.000319	CcSEcCtD
Fluticasone Propionate—Dexamethasone—NR3C1—glaucoma	6.09e-05	0.0113	CrCbGaD
Fluticasone Propionate—Nausea—Clonidine—glaucoma	6.08e-05	0.000318	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	6.07e-05	0.00251	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—OPN4—glaucoma	6.02e-05	0.0025	CbGpPWpGaD
Fluticasone Propionate—Feeling abnormal—Timolol—glaucoma	5.99e-05	0.000314	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Timolol—glaucoma	5.95e-05	0.000311	CcSEcCtD
Fluticasone Propionate—Betamethasone—PTGS2—glaucoma	5.94e-05	0.0111	CrCbGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—BDNF—glaucoma	5.9e-05	0.00244	CbGpPWpGaD
Fluticasone Propionate—Dizziness—Betaxolol—glaucoma	5.89e-05	0.000308	CcSEcCtD
Fluticasone Propionate—NR3C1—Adipogenesis—FAS—glaucoma	5.84e-05	0.00242	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Biological oxidations—GSTT1—glaucoma	5.82e-05	0.00241	CbGpPWpGaD
Fluticasone Propionate—Urticaria—Timolol—glaucoma	5.78e-05	0.000302	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Timolol—glaucoma	5.75e-05	0.000301	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Timolol—glaucoma	5.75e-05	0.000301	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—CDKN1B—glaucoma	5.71e-05	0.00237	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—IL1A—glaucoma	5.66e-05	0.00235	CbGpPWpGaD
Fluticasone Propionate—Vomiting—Betaxolol—glaucoma	5.66e-05	0.000296	CcSEcCtD
Fluticasone Propionate—CYP3A7—Metabolism—CA5A—glaucoma	5.64e-05	0.00234	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—NARFL—glaucoma	5.64e-05	0.00234	CbGpPWpGaD
Fluticasone Propionate—Rash—Betaxolol—glaucoma	5.61e-05	0.000294	CcSEcCtD
Fluticasone Propionate—Dermatitis—Betaxolol—glaucoma	5.61e-05	0.000293	CcSEcCtD
Fluticasone Propionate—Headache—Betaxolol—glaucoma	5.58e-05	0.000292	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PTGFR—glaucoma	5.42e-05	0.00225	CbGpPWpGaD
Fluticasone Propionate—Hypersensitivity—Timolol—glaucoma	5.36e-05	0.00028	CcSEcCtD
Fluticasone Propionate—PGR—Signaling by ERBB4—CDKN1B—glaucoma	5.31e-05	0.0022	CbGpPWpGaD
Fluticasone Propionate—Nausea—Betaxolol—glaucoma	5.29e-05	0.000277	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—MMP9—glaucoma	5.29e-05	0.00219	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—NGF—glaucoma	5.24e-05	0.00217	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	5.19e-05	0.00215	CbGpPWpGaD
Fluticasone Propionate—Pruritus—Timolol—glaucoma	5.15e-05	0.000269	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—LRP12—glaucoma	5.13e-05	0.00213	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Biological oxidations—GSTM1—glaucoma	5.13e-05	0.00213	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metapathway biotransformation—GSTM1—glaucoma	5.06e-05	0.0021	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	5.01e-05	0.00207	CbGpPWpGaD
Fluticasone Propionate—Diarrhoea—Timolol—glaucoma	4.98e-05	0.00026	CcSEcCtD
Fluticasone Propionate—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	4.94e-05	0.00205	CbGpPWpGaD
Fluticasone Propionate—Dizziness—Timolol—glaucoma	4.81e-05	0.000252	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—FN1—glaucoma	4.67e-05	0.00194	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Biological oxidations—CYP1B1—glaucoma	4.64e-05	0.00192	CbGpPWpGaD
Fluticasone Propionate—Vomiting—Timolol—glaucoma	4.63e-05	0.000242	CcSEcCtD
Fluticasone Propionate—Rash—Timolol—glaucoma	4.59e-05	0.00024	CcSEcCtD
Fluticasone Propionate—Dermatitis—Timolol—glaucoma	4.58e-05	0.00024	CcSEcCtD
Fluticasone Propionate—CYP3A5—Metapathway biotransformation—CYP1B1—glaucoma	4.58e-05	0.0019	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TGFB2—glaucoma	4.57e-05	0.00189	CbGpPWpGaD
Fluticasone Propionate—Headache—Timolol—glaucoma	4.56e-05	0.000238	CcSEcCtD
Fluticasone Propionate—PGR—Signaling Pathways—OPN4—glaucoma	4.36e-05	0.0018	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—CDKN2B—glaucoma	4.34e-05	0.0018	CbGpPWpGaD
Fluticasone Propionate—Nausea—Timolol—glaucoma	4.32e-05	0.000226	CcSEcCtD
Fluticasone Propionate—CYP3A5—Metabolism—CA5A—glaucoma	4.08e-05	0.00169	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NARFL—glaucoma	4.08e-05	0.00169	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	4.06e-05	0.00168	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HEYL—glaucoma	4.05e-05	0.00168	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CA1—glaucoma	3.96e-05	0.00164	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTGFR—glaucoma	3.92e-05	0.00162	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CTSA—glaucoma	3.83e-05	0.00159	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	3.82e-05	0.00158	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—NR3C1—glaucoma	3.81e-05	0.00158	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Biological oxidations—GSTM1—glaucoma	3.71e-05	0.00154	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metapathway biotransformation—GSTM1—glaucoma	3.66e-05	0.00152	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CA2—glaucoma	3.62e-05	0.0015	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	3.61e-05	0.0015	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—TP53—glaucoma	3.59e-05	0.00149	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—OPN4—glaucoma	3.56e-05	0.00147	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.54e-05	0.00147	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.54e-05	0.00147	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—SOD1—glaucoma	3.46e-05	0.00143	CbGpPWpGaD
Fluticasone Propionate—Dexamethasone—PTGS2—glaucoma	3.46e-05	0.00644	CrCbGaD
Fluticasone Propionate—NR3C2—Gene Expression—CDKN2B—glaucoma	3.43e-05	0.00142	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HEYL—glaucoma	3.31e-05	0.00137	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTGFR—glaucoma	3.2e-05	0.00133	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—TP53—glaucoma	3.16e-05	0.00131	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—RPTOR—glaucoma	3.07e-05	0.00127	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—NR3C1—glaucoma	3.01e-05	0.00125	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	3.01e-05	0.00125	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NCK2—glaucoma	2.97e-05	0.00123	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CA1—glaucoma	2.76e-05	0.00114	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—SMO—glaucoma	2.73e-05	0.00113	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—GSTT1—glaucoma	2.71e-05	0.00112	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—glaucoma	2.68e-05	0.00111	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CTSA—glaucoma	2.67e-05	0.00111	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—MMP1—glaucoma	2.64e-05	0.00109	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.58e-05	0.00107	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—TXN—glaucoma	2.55e-05	0.00106	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—CAV1—glaucoma	2.53e-05	0.00105	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HDAC9—glaucoma	2.53e-05	0.00105	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CA2—glaucoma	2.52e-05	0.00104	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—CDKN2B—glaucoma	2.51e-05	0.00104	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—RPTOR—glaucoma	2.51e-05	0.00104	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—VEGFA—glaucoma	2.5e-05	0.00104	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—TNF—glaucoma	2.48e-05	0.00103	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NCK2—glaucoma	2.43e-05	0.00101	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—FN1—glaucoma	2.41e-05	0.000998	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.33e-05	0.000964	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.3e-05	0.000955	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.27e-05	0.000941	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—CYP1B1—glaucoma	2.16e-05	0.000894	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—TNF—glaucoma	2.14e-05	0.000888	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	2.13e-05	0.000881	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—CDKN2B—glaucoma	2.09e-05	0.000866	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HDAC9—glaucoma	2.06e-05	0.000855	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CA1—glaucoma	1.99e-05	0.000826	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SMO—glaucoma	1.98e-05	0.000819	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GSTT1—glaucoma	1.98e-05	0.000819	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CTSA—glaucoma	1.93e-05	0.0008	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—NOS3—glaucoma	1.91e-05	0.000793	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CA5A—glaucoma	1.9e-05	0.000786	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NARFL—glaucoma	1.9e-05	0.000786	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—NR3C1—glaucoma	1.83e-05	0.00076	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CA2—glaucoma	1.82e-05	0.000755	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NTRK2—glaucoma	1.81e-05	0.000749	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—EDN1—glaucoma	1.8e-05	0.000747	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—TXN—glaucoma	1.78e-05	0.000736	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.72e-05	0.000714	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.7e-05	0.000704	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SMO—glaucoma	1.62e-05	0.000669	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.59e-05	0.00066	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—C3—glaucoma	1.57e-05	0.000653	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CYP1B1—glaucoma	1.57e-05	0.000652	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ABCA1—glaucoma	1.57e-05	0.000652	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NGFR—glaucoma	1.55e-05	0.000643	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NTRK2—glaucoma	1.48e-05	0.000612	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NTRK1—glaucoma	1.47e-05	0.000611	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—VEGFA—glaucoma	1.38e-05	0.000571	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GSTT1—glaucoma	1.38e-05	0.000571	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CDKN2B—glaucoma	1.36e-05	0.000563	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EDN1—glaucoma	1.3e-05	0.00054	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—TXN—glaucoma	1.28e-05	0.000532	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NGFR—glaucoma	1.27e-05	0.000525	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GSTM1—glaucoma	1.26e-05	0.000522	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—CDKN2B—glaucoma	1.21e-05	0.0005	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NTRK1—glaucoma	1.2e-05	0.000499	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NGF—glaucoma	1.2e-05	0.000496	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—C3—glaucoma	1.14e-05	0.000472	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—MTHFR—glaucoma	1.11e-05	0.000461	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDKN2B—glaucoma	1.11e-05	0.00046	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ABCA1—glaucoma	1.1e-05	0.000455	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP1B1—glaucoma	1.1e-05	0.000455	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EDN1—glaucoma	1.07e-05	0.000441	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—APOE—glaucoma	1.06e-05	0.000439	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CAV1—glaucoma	1.05e-05	0.000435	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TP53—glaucoma	1.04e-05	0.000432	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—APOE—glaucoma	1.04e-05	0.000429	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CAV1—glaucoma	1.03e-05	0.000425	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FN1—glaucoma	1e-05	0.000414	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTT1—glaucoma	9.96e-06	0.000413	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—BAD—glaucoma	9.88e-06	0.000409	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NGF—glaucoma	9.79e-06	0.000405	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—C3—glaucoma	9.3e-06	0.000385	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CA1—glaucoma	9.26e-06	0.000384	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CTSA—glaucoma	8.97e-06	0.000372	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GSTM1—glaucoma	8.77e-06	0.000363	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—APOE—glaucoma	8.66e-06	0.000359	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CAV1—glaucoma	8.58e-06	0.000356	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CA2—glaucoma	8.47e-06	0.000351	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FN1—glaucoma	8.17e-06	0.000338	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—BAD—glaucoma	8.07e-06	0.000334	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NOS3—glaucoma	7.94e-06	0.000329	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ABCA1—glaucoma	7.93e-06	0.000329	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP1B1—glaucoma	7.93e-06	0.000329	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—NOS3—glaucoma	7.76e-06	0.000322	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—MTHFR—glaucoma	7.75e-06	0.000321	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—APOE—glaucoma	7.22e-06	0.000299	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CAV1—glaucoma	7.15e-06	0.000296	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTGS2—glaucoma	7.1e-06	0.000294	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CDKN1B—glaucoma	6.88e-06	0.000285	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NOS3—glaucoma	6.49e-06	0.000269	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MMP9—glaucoma	6.37e-06	0.000264	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTM1—glaucoma	6.34e-06	0.000263	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—TXN—glaucoma	5.97e-06	0.000247	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—VEGFA—glaucoma	5.72e-06	0.000237	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDKN1B—glaucoma	5.62e-06	0.000233	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—MTHFR—glaucoma	5.6e-06	0.000232	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—NOS3—glaucoma	5.41e-06	0.000224	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—APOE—glaucoma	5.22e-06	0.000216	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MMP9—glaucoma	5.21e-06	0.000216	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CAV1—glaucoma	5.17e-06	0.000214	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTGS2—glaucoma	4.95e-06	0.000205	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—VEGFA—glaucoma	4.67e-06	0.000194	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTT1—glaucoma	4.63e-06	0.000192	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TP53—glaucoma	4.32e-06	0.000179	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NOS3—glaucoma	3.91e-06	0.000162	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ABCA1—glaucoma	3.69e-06	0.000153	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP1B1—glaucoma	3.69e-06	0.000153	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTGS2—glaucoma	3.58e-06	0.000148	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TP53—glaucoma	3.53e-06	0.000146	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTM1—glaucoma	2.95e-06	0.000122	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—MTHFR—glaucoma	2.61e-06	0.000108	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—APOE—glaucoma	2.43e-06	0.000101	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CAV1—glaucoma	2.4e-06	9.96e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NOS3—glaucoma	1.82e-06	7.53e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTGS2—glaucoma	1.66e-06	6.89e-05	CbGpPWpGaD
